Other studies have also demonstrated the diagnostic utility of CSF ctDNA analysis, with mutation profiles generally consistent with the primary tumour type (e.g., NRAS and BRAF mutations from melanoma patients and EGFR mutations for lung BrM patients [42]). Here, NRAS is linked to neoplasm.